Osmotica Pharmaceutical
IPO News: File S-1: Osmotica Pharmaceutical files $100mm IPO
Osmotica Pharmaceutical

Osmotica Pharmaceutical

NASDAQ: OSMT

Initial Filing Date:  09/14/18

Size:  $100mm

Bookrunners:  JEFF | BARC | RBC

Major Holders:  Avista Capital Partners | Altchem

Description: Osmotica Pharmaceutical is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations.

Note: Emerging Growth Company

Reference Link:  S-1